We have interest in the high-throughput asymmetric cyclopropanation of olefins using newly synthesized dirhodium (II) complexes in a new one pot approach directed by the in situ generation of phenyl iodonium ylides. The approach is used to access to biologically active enantiomerically pure entities that can serve as active ingredient of a drug.